Hycodan and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Hycodan (homatropine methylbromide; hydrocodone bitartrate), especially for people who are female, 60+ old, also take Ativan, and have Nausea.
The phase IV clinical study analyzes which people have Weakness when taking Hycodan. It is created by eHealthMe based on reports of 713 people who have side effects when taking Hycodan from the FDA, and is updated regularly.
What is Hycodan?
Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.
What is Weakness?
Weakness is found to be associated with 3,639 drugs and 6,565 conditions by eHealthMe. Check the latest studies of Weakness.
713 people reported to have side effects when taking Hycodan.
Among them, 65 people (9.12%) have Weakness.
Among these 65 people:
What is the gender of people who have Weakness when taking Hycodan? *
What is the age of people who have Weakness when taking Hycodan? *
What are other drugs people take besides Hycodan? *
What are other side effects people have besides Weakness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Hycodan and have Weakness?
- Check whether Weakness is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Hycodan:
- Hycodan (769 reports)
Weakness treatments and more:
- Weakness (586,868 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of homatropine methylbromide; hydrocodone bitartrate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Hycodan side effects:
- Hycodan side effect: Cough (109 reports)
Browse all side effects of Hycodan:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Weakness:
- Prednisone side effect: Weakness (33,014 reports)
- Aspirin side effect: Weakness (31,402 reports)
- Methotrexate side effect: Weakness (19,933 reports)
- Humira side effect: Weakness (19,823 reports)
- Metformin side effect: Weakness (18,763 reports)
- Omeprazole side effect: Weakness (18,026 reports)
- Vitamin d side effect: Weakness (16,779 reports)
- Pantoprazole side effect: Weakness (16,471 reports)
- Lisinopril side effect: Weakness (16,349 reports)
- Amlodipine side effect: Weakness (16,333 reports)
Browse all the drugs that are associated with Weakness:
- Weakness (3,639 drugs)
Common conditions associated with Weakness:
- Multiple sclerosis aggravated: 47,411 reports
- Rheumatoid arthritis aggravated: 27,357 reports
- Arthritis - rheumatoid: 27,340 reports
- Hypertension: 27,087 reports
- Htn: 26,940 reports
- Blood pressure increased: 26,939 reports
- High blood cholesterol: 19,135 reports
- Blood cholesterol increased: 19,025 reports
- Lipoprotein test: 17,735 reports
- Pain: 16,824 reports
Browse all the conditions that are associated with Weakness:
- Weakness (6,565 conditions)
Drugs similar to Hycodan and Weakness :
How the study uses the data?
The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate (the active ingredients of Hycodan) and Hycodan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ezetimibe cause Lichen Planus? - 7 seconds ago
- Gaviscon and Dexamethasone drug interactions for women aged 60+ - 7 seconds ago
- Tramadol Hydrochloride and Not Effective for Women aged 50-59 - 9 seconds ago
- Tramadol Hydrochloride and Drug Ineffective for Women aged 50-59 - 10 seconds ago
- Synthroid and Nms for Women aged 60+ - 10 seconds ago
- Synthroid and Neuroleptic Malignant Syndrome for Women aged 60+ - 11 seconds ago
- Aripiprazole and Drug Abuser for Boys aged 10-19 - 13 seconds ago
- Aripiprazole and Drug Abuse for Boys aged 10-19 - 13 seconds ago
- Aripiprazole and Drug Addiction for Boys aged 10-19 - 14 seconds ago
- Aripiprazole and Addiction - Drug for Boys aged 10-19 - 14 seconds ago